Clinical Trials for CureVac

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CureVac

Clinical Trials (2)

NCT07073183
Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
PHASE1Not yet recruiting
36 participants
Started: Jul 30, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor13 locations
NCT05938387
Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PHASE1Active, not recruiting
37 participants
Started: Jun 1, 2023 · Completed: Feb 4, 2026
1 condition1 sponsor13 locations